Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines-Reference-Cited by-同舟云学术

Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines

Published:2006-05 Issue:5 Volume:30 Page:625-631
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Takei Kazuhiro,Yamazaki Tetsuo,Sawada Umihiko,Ishizuka Hikari,Aizawa Shin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference31 articles.

1. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20;Reff;Blood,1994

2. CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells;Selenko;Leukemia,2001

3. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways;Mathas;Cancer Res,2000

4. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells;Shan;Cancer Immunol Immunother,2000

5. IDEC-C2B8: result of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma;Maloney;J Clin Oncol,1997

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD20 expression regulates CD37 levels in B-cell lymphoma – implications for immunotherapies;OncoImmunology;2024-06-04

2. Pharmacology to Practice;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Non-Hodgkin lymphoma treated with anti-CD20 antibody-based immunochemotherapy;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Mechanisms of resistance to anti-CD20 antibodies in lymphoid malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

5. CD20 expression regulates CD37 levels in B-cell lymphoma – implications for immunotherapies;2023-12-08